Inovio Pharmaceuticals (0A43) Short Interest
LSE • 0A43 • US45773H4092
As of Oct 27, 2026, ORTEX estimated 5.6% of free float sold short, 154.7 days to cover, cost to borrow 2.69%. Sign up for live short interest data.
LSE • 0A43 • US45773H4092
As of Oct 27, 2026, ORTEX estimated 5.6% of free float sold short, 154.7 days to cover, cost to borrow 2.69%. Sign up for live short interest data.
This page tracks how heavily Inovio Pharmaceuticals (LSE:0A43) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Inovio Pharmaceuticals (LSE: 0A43) has a market capitalization of $265.87M. Last close $1.36 (as of 2026-11-12); 52-week range $0.57 to $2.72. ORTEX data as of 2026-10-27: short interest was 5.62% of free float, 154.7 days to cover and the average cost to borrow was 2.69%. Sign up for live short interest data.